Longtime local advertising executive Kaz Endo said he has applied for the position of general manager for the Guam Visitors Bureau, which closed its application period Wednesday. GVB has not ...

One particularly intriguing character revealed in the latest episode is Yamato Endo. Yamato Endo is a key antagonist in the Wind Breaker series and serves as the main overarching antagonist of the ...

Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint. The companies said Thursday they reached a definitive ...

Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...

(RTTNews) - Specialty pharmaceutical companies Mallinckrodt plc and Endo, Inc. announced Thursday that they have entered into a definitive agreement to combine in a stock and cash transaction.

Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both companies a roughly 50 ...

Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments. The agreement will give ...

Net Leverage of Approximately 2.3x Expected at Close Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the ...

Mallinckrodt plc and Endo, Inc. today announced that they have entered into a definitive agreement to combine in a stock and cash transaction to create a global, scaled, diversified ...

Mallinckrodt and Endo said they will merge through a $6.7 billion cash and stock deal creating a combined company that will be intent on bouncing back from their troubled recent histories ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair ...

MALVERN, Pa., March 11, 2025 /CNW/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals ...